Predictive value of baseline metabolic tumor volume for non-small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) have emerged as a promising treatment option for advanced non-small-cell lung cancer (NSCLC) patients, highlighting the need for biomarkers to identify responders and predict the outcome of ICIs. The purpose of this study was to evaluate the predictive...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ke, Su, Danqian, Wang, Jianing, Cheng, Zhouen, Chin, Yiqiao, Chen, Luyin, Chan, Chingtin, Zhang, Rongcai, Gao, Tianyu, Ben, Xiaosong, Jing, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487526/
https://www.ncbi.nlm.nih.gov/pubmed/36147904
http://dx.doi.org/10.3389/fonc.2022.951557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487526/
https://www.ncbi.nlm.nih.gov/pubmed/36147904
http://dx.doi.org/10.3389/fonc.2022.951557

Ejemplares similares